GBA2 Gene Cerebellar Ataxia with Spasticity Genetic Test
At DNA Labs UAE, we offer the GBA2 Gene Cerebellar Ataxia with Spasticity Genetic Test. This test is designed to detect mutations in the GBA2 gene, which is associated with a rare genetic disorder called cerebellar ataxia with spasticity.
Test Components and Price
The GBA2 Gene Cerebellar Ataxia with Spasticity Genetic Test is priced at 4400.0 AED. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.
Report Delivery
After the sample is collected, the report will be delivered within 3 to 4 weeks.
Method
The test utilizes NGS (Next-Generation Sequencing) technology to analyze the patient’s DNA.
Test Type
The GBA2 Gene Cerebellar Ataxia with Spasticity Genetic Test falls under the category of neurological disorders.
Doctor and Test Department
This test is conducted by a neurologist and falls under the genetics department.
Pre Test Information
Prior to undergoing the GBA2 Gene Cerebellar Ataxia with Spasticity Genetic Test, it is recommended to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by this disorder.
Test Details
Cerebellar ataxia with spasticity is a rare genetic disorder characterized by the progressive degeneration of the cerebellum, which controls movement and coordination, as well as spasticity, which causes muscle stiffness and difficulty with movement. The GBA2 gene is associated with this disorder.
NGS genetic testing is used to identify mutations in the GBA2 gene, aiding in the diagnosis of cerebellar ataxia with spasticity. This advanced testing method analyzes the patient’s DNA using next-generation sequencing technology to identify any genetic changes that may be responsible for the disorder.
If a mutation in the GBA2 gene is detected through NGS genetic testing, it can provide crucial information for the patient and their family. It can confirm the diagnosis, guide treatment decisions, and offer insights into the risk of passing on the disorder to future generations.
Overall, NGS genetic testing for cerebellar ataxia with spasticity improves the accuracy and speed of diagnosis, providing valuable information for patients and their families.
For more information or to schedule an appointment for the GBA2 Gene Cerebellar Ataxia with Spasticity Genetic Test, please contact DNA Labs UAE.
| Test Name | GBA2 Gene Cerebellar ataxia with spasticity Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for GBA2 Gene Cerebellar ataxia with spasticity NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GBA2 Gene Cerebellar ataxia with spasticity |
| Test Details |
The GBA2 gene is associated with a rare genetic disorder called cerebellar ataxia with spasticity. This disorder is characterized by a progressive degeneration of the cerebellum, which is the part of the brain that controls movement and coordination, and spasticity, which is a condition that causes muscle stiffness and difficulty with movement. NGS genetic testing can be used to detect mutations in the GBA2 gene, which can help diagnose cerebellar ataxia with spasticity. This type of testing uses next-generation sequencing technology to analyze a patient’s DNA and identify any genetic changes that may be responsible for the disorder. If a mutation in the GBA2 gene is identified through NGS genetic testing, it can provide important information for the patient and their family. It can help confirm a diagnosis, guide treatment decisions, and provide information about the risk of the disorder being passed on to future generations. Overall, NGS genetic testing for cerebellar ataxia with spasticity can help improve the accuracy and speed of diagnosis, as well as provide valuable information for patients and their families. |
